Second Annual Agi Hirshberg Symposium on Pancreatic Cancer

SECOND ANNUAL AGI HIRSHBERG SYMPOSIUM ON PANCREATIC CANCER

Monday, January 30, 2006

7:30 a.m. – 5:00 p.m.

California Room, UCLA Faculty Center

PROGRAM SCHEDULE

7:30 – 8:20 a.m.	CONTINENTAL BREAKFAST
8:20 – 8:30 a.m.	WELCOME AND OPENING REMARKS Agi Hirshberg Founder & CEO Hirshberg Foundation for Pancreatic Cancer Research
8:30 – 8:40 a.m.	HIRSHBERG FOUNDATION’S RESEARCH MISSION ACCOMPLISHMENTS Vay Liang W. Go, MD UCLA Department of Medicine
Morning Session: CLINICAL RESEARCH IN PANCREATIC CANCER
8:40 – 8:50 a.m.	Introduction Howard A. Reber, MD UCLA Department of Surgery
8:50 – 9:25 a.m.	National Comprehensive Cancer Network Practice Guidelines on Pancreatic Cancer Stephen I. Shibata, MD Department of Medical Oncology City of Hope National Medical Center
9:25 – 10:00 a.m.	Evidence-Based Chemotherapy for Pancreatic Cancer William H. Isacoff, MD UCLA Division of Hematology-Oncology
10:00 – 10:35 a.m.	Saliva Test for Pancreatic Cancer David T.W. Wong, DMD, DMSc UCLA School of Dentistry
10:35 – 11:10 a.m.	Pancreatic Cancer Pharmacogenomics James Farrell, MD UCLA Division of Digestive Disease

11:10 – 11:40 a.m.	Pancreatic Cancer Tracer Metabolomics WN Paul Lee, MD LABiomed Research Institute at Harbor-UCLA Medical Center
11:40 a.m. – 12:00 p.m.	Fructose Metabolism in Pancreatic Cancer Cell Growth Anthony P. Heaney, MD, PhD Cedars-Sinai Medical Center
12:00 – 1:30 p.m.	LUNCH BREAK
Afternoon Session: NEW FRONTIER IN BASIC SCIENCES RESEARCH
1:30 – 1:40 p.m.	Introduction: Inflammation and Pancreatic Cancer Guido Eibl, MD UCLA Department of Surgery
1:40 – 2:00 p.m.	Role of Chemokines in Pancreatic Carcinogenesis O. Joe Hines, MD UCLA Department of Surgery
2:00 – 2:20 p.m.	Manipulating the Lipoxygenase Pathways for Pancreatic Cancer Prevention/Treatment Diane M. Harris, PhD UCLA Center for Human Nutrition
2:20 – 2:30 p.m.	SESSION BREAK
2:30 – 2:40 p.m.	Introduction: Trophic Factors in Pancreatic Cancer J. Enrique Rozengurt, DVM, PhD UCLA Division of Digestive Diseases
2:40 – 3:00 p.m.	PKD Translocations in Pancreatic Cancer Cells Krisztina Kisfalvi, MD, PhD UCLA Division of Digestive Diseases
3:00 – 3:20 p.m.	Synergistic Interactions Between G Protein-coupled Receptors and Tyrosine Kinase Receptors in Pancreatic Cancer Cells Osvaldo Rey, PhD UCLA Division of Digestive Diseases
3:20 – 3:30 p.m.	SESSION BREAK

3:30 – 3:40 p.m.	Introduction: Cell Death Mechanisms in Malignant and Non-Malignant Pancreatic Tissue Stephen J. Pandol, MD UCLA Department of Medicine VA Greater Los Angeles Healthcare System
3:40 – 4:00 p.m.	Survivin Regulation of Apoptosis in Pancreatic Cancer Nathan R. Wall, PhD Loma Linda University
4:00 – 4:20 p.m.	Cell Death in Pancreatitis: Caspases Protect From Necrotizing Pancreatitis Olga A. Mareninova, PhD UCLA Department of Medicine VA Greater Los Angeles Healthcare System
4:20 – 4:40 p.m.	GF-R Trans-activation by Fibronectin Protects Pancreatic Cancer Cells From Apoptosis Mouad Edderkaoui, PhD UCLA Department of Medicine VA Greater Los Angeles Healthcare System
4:40 – 5:00 p.m.	CLOSING REMARKS Agi Hirshberg

Footer Promotions Hirshberg